FTSE Russell Cello Health (0961V)
August 04 2020 - 12:30PM
UK Regulatory
TIDMCLL
RNS Number : 0961V
FTSE Russell
04 August 2020
Cello Health (UK): Constituent Deletion
Changes in FTSE UK Index Series
04 August 2020
Subject to court sanctioning the scheme of arrangement in relation to the cash offer for Cello
Health (UK, constituent) by Pharma Value Demonstration Bidco Ltd (non constituent), please
see details of affected indexes and effective dates below:
Index Effective From
Start of Trading
FTSE AIM All-Share Index 11 August 2020
For further information please contact FTSE Russell Client Services at info@ftserussell.com
or call: Australia +1800 653 680
Hong Kong +852 2164 3333
Japan +81 3 4563 6346
London +44 (0) 20 7866 1810
New York +1866 551 0617
Alternatively please visit our website at www.ftserussell.com
Terms of Use | Copyright (c) 2020 FTSE Russell
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
FTSFLFSITRISIII
(END) Dow Jones Newswires
August 04, 2020 12:30 ET (16:30 GMT)
Cello Health (LSE:CLL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cello Health (LSE:CLL)
Historical Stock Chart
From Sep 2023 to Sep 2024